Skip to main content
. 2022 Jul 12;13:936121. doi: 10.3389/fgene.2022.936121

TABLE 1.

Demographical data of the children included in the study.

M (N = 269) F (N = 398) Total (N = 667)
At first examination at our clinic
 Age 6.4 (5.8, 7.4) 6.3 (5.8, 7.1) 6.3 (5.8, 7.2)
 Weight kg 24.4 (21.3, 29.6) 22.8 (20.1, 27.5) 23.4 (20.5, 28.4)
 Height cm 122.0 (117.0, 130.3) 120.5 (115.5, 127.0) 121.2 (116.0, 128.5)
 LDL-C mmol/L 3.4 (2.9, 3.9) 3.5 (3.1, 4.1) 3.5 (3.0, 4.1)
mg/dL 131.5 (112.1, 150.8) 135.3 (119.9, 158.5) 135.3 (116.0, 158.5)
 TC mmol/L 5.5 (5.0, 5.9) 5.6 (5.1, 6.1) 5.5 (5.0, 6.0)
mg/dL 212.7 (193.4, 228.2) 216.6 (197.2, 235.9) 212.7 (193.4, 232.0)
 HDL-C mmol/L 1.5 (1.3, 1.7) 1.5 (1.3, 1.8) 1.5 (1.3, 1.8)
mg/dL 58.0 (50.3, 65.7) 58.0 (50.3, 69.6) 58.0 (50.3, 69.6)
 TG mmol/L 0.9 (0.7, 1.4) 0.9 (0.7, 1.3) 0.9 (0.7, 1.3)
mg/dL 79.7 (62.0, 124.0) 79.7 (62.0, 115.1) 79.7 (62.0, 115.1)
 AST µkat/L 0.5 (0.4, 0.6) 0.5 (0.4, 0.6) 0.5 (0.4, 0.6)
 ALT µkat/L 0.3 (0.3, 0.4) 0.3 (0.3, 0.4) 0.3 (0.3, 0.4)

Age, weight, height, and lipid profile of the cohort were included in the LIPA sequencing, at the first examination at our clinic. Data are presented as median (IQR). LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; AST, aspartate transaminase; ALT, alanine transaminase.